Narayana Hrudayalaya Limited, a leading healthcare service provider in India, has announced its financial results for the first quarter, showcasing a mix of growth and challenges.

Revenue Growth

The company reported a consolidated operating revenue of ₹15,073.00 million for Q1, marking a significant year-on-year growth of 15.4% compared to ₹13,063.00 million in the same quarter of the previous year. This robust increase in revenue demonstrates the company's continued expansion and market presence in the healthcare sector.

Profit Performance

Despite the strong revenue growth, Narayana Hrudayalaya experienced a slight decline in profitability. The consolidated Profit After Tax (PAT) stood at ₹1,961.00 million for Q1, down 2.3% from ₹2,006.00 million in the same period last year. The PAT margin decreased to 13.0% from 15.4% year-over-year.

EBITDA and Margin

The company's consolidated EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) showed positive growth, reaching ₹3,607.00 million in Q1, a 10.7% increase from ₹3,258.00 million in the same quarter of the previous year. However, the EBITDA margin experienced a slight contraction, moving from 24.9% to 23.9% year-over-year.

Segment Performance

• India Operations: The India revenue grew by 7.8% year-on-year to ₹11,326.00 million in Q1.
• Cayman Islands: The Cayman Islands facility showed remarkable growth, with revenue increasing by 48.4% year-on-year to ₹3,968.00 million.

Operational Highlights

Narayana Hrudayalaya continued to expand its services and capabilities across various facilities:

• Rabindranath Tagore International Institute of Cardiac Sciences, Kolkata, operationalized a new block and successfully completed a pneumatic chute installation.
• MMI Narayana Hospital, Raipur performed its first aortic valve preserving aortic replacement & total arch replacement surgery.
• Narayana Superspeciality Hospital, Guwahati successfully treated a 3-year-old for hepatoblastoma, a rare and aggressive liver cancer.
• Narayana Multispeciality Hospital, HSR (Bangalore) performed its first Mitra clip procedure in Q1.

Management Commentary

Dr. Emmanuel Rupert, Managing Director and Group CEO of Narayana Hrudayalaya Limited, commented on the performance: "The first quarter of the new fiscal year has started with a robust performance. We are pleased to report the highest-ever revenue on a quarterly basis with profit margins sustaining at high levels. The performance improvement in India is attributable to increased footfall in the domestic business, improvement in realizations, optimization in payor categories, and positive traction from our Clinics outreach."

He also highlighted the strong performance of the Cayman business and the growth potential of the Integrated Care business.

Financial Position

As of the end of the quarter, the company's net debt to equity ratio stood at 0.09, with total borrowings less cash & bank balance and investments at ₹3,430.00 million.

Narayana Hrudayalaya's Q1 results reflect its ability to drive revenue growth in a challenging environment, while also highlighting the need to manage costs and improve profitability. The company's focus on expanding its services and geographical presence continues to contribute to its top-line growth.

Narayana Hrudayalaya Limited , a prominent healthcare provider, has announced a crucial board meeting scheduled for August 1, 2025. The meeting agenda includes two significant items that could impact the company's financial trajectory and operational capabilities.

Financial Results Review

The board of directors will convene to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025. This review will provide stakeholders with insights into the company's performance during the first quarter of the fiscal year 2025-26.

Debt Fundraising Proposal

In addition to the financial results, the board will examine a revised proposal for raising funds through debt securities. The company is considering issuing these securities via private placement, potentially in multiple tranches. This strategic move aims to bolster the company's financial resources, possibly for expansion or operational improvements.

Shareholder Approval and AGM

It's important to note that the debt fundraising proposal will be subject to shareholder approval. The company has scheduled its Annual General Meeting (AGM) for August 29, 2025, where shareholders will have the opportunity to vote on this matter.

Regulatory Compliance

Narayana Hrudayalaya has duly informed the stock exchanges about the upcoming board meeting, adhering to Regulations 29 and 50(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This transparency ensures that all stakeholders are kept informed about significant corporate events.

Conclusion

The outcomes of this board meeting could have substantial implications for Narayana Hrudayalaya's financial structure and future growth strategies. Investors and market analysts will be keenly watching for the Q1 results and any details that emerge regarding the potential debt issuance.

For more information, stakeholders can visit the company's official website at www.narayanahealth.org , where the disclosure will be made available following the board meeting.